Andrew Huberman· PhD
even just differences in receptor subtypes leading to profoundly different subjective outcomes, I find that to be just one of the most important areas that one could even think about, let alone work on.
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
even just differences in receptor subtypes leading to profoundly different subjective outcomes, I find that to be just one of the most important areas that one could even think about, let alone work on.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And why would increasing the activity of a particular serotonin receptor or batch of serotonin receptors lead to these profoundly different experiences that we're calling um model challenges challenging pre-existing models and predictions?